SUPPRESSION OF DEVELOPMENT OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS WITH ISOGENEIC MONOCLONAL ANTIIDIOTOPIC ANTIBODY

被引：0
|
作者：
AGIUS, MA [1 ]
RICHMAN, DP [1 ]
机构：
[1] UNIV CHICAGO,BRAIN RES INST,CHICAGO,IL 60637
来源：
JOURNAL OF IMMUNOLOGY | 1986年 / 137卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2195 / 2198
页数：4
相关论文
共 50 条
  • [41] ROLE OF THE MACROPHAGE IN THE PATHOGENESIS OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS
    KINOSHITA, I
    NAKAMURA, T
    SATOH, A
    MATSUO, H
    SETO, M
    TOMITA, I
    TSUJIHATA, M
    NAGATAKI, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1988, 87 (01) : 49 - 59
  • [42] ENDPLATE POTENTIALS IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS IN RATS
    LAMBERT, EH
    LINDSTROM, JM
    LENNON, VA
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 274 (MAY28) : 300 - 318
  • [43] IMMUNOSUPPRESSION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS BY HYDROCORTISONE AND AZATHIOPRINE
    ABRAMSKY, O
    TARRABHAZDAI, R
    AHARONOV, A
    FUCHS, S
    JOURNAL OF IMMUNOLOGY, 1976, 117 (01): : 225 - 228
  • [44] ROLE OF ACETYLCHOLINE-RECEPTOR ANTIBODY COMPLEXES IN MUSCLE IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS
    VERSCHUUREN, JJGM
    GRAUS, YMF
    THEUNISSEN, ROM
    YAMAMOTO, T
    VINCENT, A
    VRIESMAN, PJCV
    DEBAETS, MH
    JOURNAL OF NEUROIMMUNOLOGY, 1992, 36 (2-3) : 117 - 125
  • [45] MODULATION OF ANTIACETYLCHOLINE RECEPTOR ANTIBODY SPECIFICITIES AND OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS BY SYNTHETIC PEPTIDES
    SOUROUJON, MC
    CARMON, S
    FUCHS, S
    IMMUNOLOGY LETTERS, 1992, 34 (01) : 19 - 25
  • [46] IFN-ALPHA TREATMENT SUPPRESSES THE DEVELOPMENT OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS
    SHENOY, M
    BARON, S
    WU, B
    GOLUSZKO, E
    CHRISTADOSS, P
    JOURNAL OF IMMUNOLOGY, 1995, 154 (11): : 6203 - 6208
  • [47] ANTIBODY SPECIFICITY IN MYASTHENIA-GRAVIS
    VINCENT, A
    WOOD, H
    MONOGRAPHS IN ALLERGY, 1988, 25 : 33 - 40
  • [48] SYMPATHECTOMY ENHANCES THE SEVERITY OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG)
    AGIUS, MA
    CHECINSKI, ME
    RICHMAN, DP
    CHELMICKASCHORR, E
    JOURNAL OF NEUROIMMUNOLOGY, 1987, 16 (01) : 11 - 12
  • [49] Prevention and reversal of experimental autoimmune myasthenia gravis by monoclonal antibody to a complementary peptide.
    Xu, L
    Araga, S
    Villain, M
    Galin, FS
    Blalock, JE
    FASEB JOURNAL, 1999, 13 (05): : A1123 - A1123
  • [50] ANTIIDIOTYPIC ANTIBODIES IN THE STUDY AND TREATMENT OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS
    SOUROUJON, MC
    FUCHS, S
    METHODS IN ENZYMOLOGY, 1989, 178 : 433 - 448
12345